Asset Publisher

null Should I provide grounds for use if the product has been granted a marketing authorisation in Finland but has not been launched on the market?

Should I provide grounds for use if the product has been granted a marketing authorisation in Finland but has not been launched on the market?

If the therapeutic indication and the target species match the marketing authorisation, presentation of grounds is not required.

10 Nov 2015

Back to previous page

Frequently asked questions